University of Exeter: Seeing the same GP improves treatment for people with dementia, study finds
The research, led by the University of Exeter and published in the British Journal of General Practice (BJGP) analysed more than 9,000patient records of people diagnosed with dementia in the Clinical Practice Research Datalink. The team found that people with dementia who were consistently seen by the same GP over the course of one year were given fewer medicines and were less likely to be given medicines that can cause problems like incontinence, drowsiness and falls. Those seeing the same GP over time were 35 per cent less likely to develop delirium, a state of confusion commonly experienced in dementia. Those who consistently saw the same GP were also 58 per cent less likely to experience incontinence, and almost ten per cent less likely to have an emergency hospitalisation, compared to those who had the most variation in GPs treating them.
The research was conducted in anonymised patient records of people with dementia aged 65 and over in 2016, who were followed-up for one year. This study includes people who visited a GP at least three times in the previous year.
Lead author Dr João Delgado, of the University of Exeter, said: “The number of people with dementia has been rising steadily and it is now one of the leading causes of death in the UK. In the absence of a cure, long-term care is particularly important. Treating people with dementia can be complex, because it often occurs together with other common diseases. Our research shows that seeing the same general practitioner consistently over time is associated with improved safe prescribing and improved health outcomes. This could have important healthcare impacts, including reduced treatment costs and care needs.”
Delirium (an episode of more severe confusion) is common in dementia, and patients who develop delirium are more likely to die. Delirium and incontinence are very distressing for individuals, and require additional NHS resource. Extra hospital admissions are a high cost for the NHS.
Sir Denis Pereira Gray, co-author and GP researcher at the St Leonard’s Practice, said: “These new findings show that GP continuity is associated with important benefits for patients. Whilst national policy makers have for years discouraged continuity, general practices can still provide good GP continuity through their internal practice organisation, for example, by using personal lists.”
Dr Richard Oakley, Associate Director of Research at Alzheimer’s Society said: “For the 900,000 people living with dementia in the UK, it’s likely dementia isn’t the only condition they’re getting treatment for.
“It’s clear from this study that consistently seeing the same GP has real benefits for people living with dementia – better management and treatment of conditions, and lower risk of complications like delirium and incontinence, leading to improved quality of life.
“The pandemic has put GP services under immense pressure, so while we might not be able to get consistent GP care for everyone with dementia tomorrow, policymakers should absolutely be working with the NHS to build this into their plans as we emerge from the pandemic.”